Autopsy report · NCT03848403

Study of Ixekizumab in Healthy Participants

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“At the protocol-specified interim analysis, the sponsor decided to stop the trial.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 6 months before it stopped.
70 participants enrolled.
Results were posted on the registry 1 year after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Eli Lilly and Company
Sponsor type: Industry
Conditions: Healthy
Interventions: Ixekizumab
Participants: 70
Sites: 2
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.